News

IDDO at the Geneva Health Forum 4 May 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

Applications open for RSTMH 2022 grant programme

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide

IDDO to make its COVID-19 studies discoverable on the Vivli platform

IDDO to share latest research at ECTMIH 2021

Preprints: it’s time to agree on terminology and best practice

ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination

Calls for clarity on pooled evidence in COVID-19 therapeutic reviews and guidelines

New report highlights growing concern of vaccine falsification

Applications for RSTMH 2021 grants open

Largest clinical trial in Africa to treat COVID-19 cases before they become severe is launched in 13 countries